Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

7.25USD
25 Mar 2019
Change (% chg)

$-0.05 (-0.68%)
Prev Close
$7.30
Open
$7.27
Day's High
$7.40
Day's Low
$7.07
Volume
75,924
Avg. Vol
44,674
52-wk High
$19.50
52-wk Low
$3.60

Latest Key Developments (Source: Significant Developments)

Catabasis Pharmaceuticals Reports Q4 Loss Per Share Of $0.85
Thursday, 14 Mar 2019 

March 14 (Reuters) - Catabasis Pharmaceuticals Inc ::CATABASIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS.Q4 LOSS PER SHARE $0.85.Q4 EARNINGS PER SHARE ESTIMATE $-0.90 -- REFINITIV IBES DATA.AS OF DECEMBER 31, 2018, CATABASIS HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $37.6 MILLION.  Full Article

Catabasis Pharmaceuticals reports third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc :Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress.Q3 loss per share $0.31.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.Catabasis Pharmaceuticals Inc - co's current operating plan provides for cash to fund operations through august 2018​.  Full Article